Pharmaceutical giant Novartis is back in court this week, in a renewed attempt to block India’s right to produce affordable ‘generic’ versions of the company’s branded medicines.
Vaccines have contributed to some of the greatest public health successes of the past century, averting 2.5 million child deaths every year and millions more bouts of illness and dis
Access to medicines poses a critical challenge in developing countries: prices are high, and new or adapted medicines and vaccines to address diseases of the developing world are lacking.
User fees for health care are a life or death issue for millions of people in poor countries. Too poor to pay, women and children are paying with their lives.
This report aims to identify key challenges arising from reform of the health-care system in Georgia, especially in primary health care, and to present some possible strategies to ad